Topics Related to Bulletins

Nivolumab and Relatlimab-rmbw Injection, for Intravenous Use (Opdualag™) HCPCS Code J9999: Billing Guidelines

Medicaid and NC Health Choice programs cover nivolumab and relatlimab-rmbw injection

SPECIAL BULLETIN COVID-19 #247: Over-the-Counter COVID-19 Tests for Home Use Pharmacy Coverage

Reminder: Point of Sale Billing Authorized in January

Healthy Opportunities Housing and Transportation Services Available

Qualifying Medicaid Standard Plan members in 33 North Carolina counties may receive housing and transportation services.

Non-Emergency Medicaid Transportation Updates - April 29

WellCare broker update, contracting with transportation brokers, emergent care reminder

SPECIAL BULLETIN COVID-19 #246: Direct Care Worker One-Time Bonus Reminders & Expectations

Data and clarifications on the DCW One-Time Bonus

Chimeric Antigen Receptor (CAR) T-Cell Therapy Reimbursement Guidelines

This information replaces the reimbursement guidelines posted in the December 2019 bulletin.

SPECIAL BULLETIN COVID-19 #245: Second Booster for Pfizer-BioNTech and Moderna Vaccines

Billing Reimbursement for second booster

SPECIAL BULLETIN COVID-19 #244: Evusheld Alternative to COVID-19 Vaccination for Some Patients

Billing Guideline for use of Evusheld

Tailored Care Management Updated Guidance (April 21, 2022)

Capacity building FAQs, guidance on the use of extenders, standard terms and conditions, and Provider Manual updates.

Reminder: As the Federal Public Health Emergency Ends, Provider Reverification Requirements are Reinstated

With the end of the federal Public Health Emergency (PHE) expected in the Summer of 2022, NC Medicaid providers will begin receiving reverification notices.